Related Experiment Videos
A possible tumor suppressor gene for parathyroid adenomas
1First Department of Surgery, Yokohama City University School of Medicine, Japan.
International Surgery
|January 1, 1996
Summary
Loss of heterozygosity (LOH) was examined in MEN-1 tumors and sporadic parathyroid adenomas using short sequence repeat polymorphisms (SSRP). All MEN-1 tumors showed allelic loss on chromosome 11q, suggesting the MEN-1 gene acts as a tumor suppressor.
Area of Science:
- Oncology
- Genetics
- Endocrinology
Background:
- Loss of heterozygosity (LOH) is a key genetic event in tumor development.
- Short sequence repeat polymorphisms (SSRP) are valuable markers for detecting LOH.
- Limited studies have investigated LOH in parathyroid tumors using SSRP markers.
Purpose of the Study:
- To investigate LOH in MEN-1 tumors and sporadic parathyroid adenomas.
- To identify the chromosomal location of the MEN-1 gene.
- To determine the role of the MEN-1 gene in sporadic parathyroid adenomas.
Main Methods:
- Analysis of LOH using SSRP markers.
- Examination of 19 MEN-1 tumors and 43 sporadic parathyroid adenomas.
- Allelotyping of chromosome 11q.
Main Results:
- All 19 MEN-1 tumors (100%) exhibited allelic loss on chromosome 11q.
- 34.9% (15/43) of sporadic parathyroid adenomas showed allelic loss at the same locus.
- No significant LOH was observed on other chromosomes.
Conclusions:
- The MEN-1 gene, a tumor suppressor, is located on chromosome 11q13.
- The MEN-1 gene plays a role in the development of sporadic parathyroid adenomas.
- LOH analysis using SSRP markers is effective for studying parathyroid tumorigenesis.